| ¿µ¹® | fibrinogen | ÇÑ±Û | ¼¶À¯¼Ò¿ø |
|---|---|---|---|
| ¼³¸í | Á¤»óÀÎÀÇ °£ÀÇ ½ÇÁú¼¼Æ÷¿¡¼ ÇÕ¼ºµÇ¾î Ç÷Àå¿¡¼ ¾ò¾îÁö´Â µ¿°á°ÇÁ¶ÇÑ ¹«±ÕÀÇ ´Ü¹é¹°Áú·Î¼ ÀÌ ¿ë¾×¿¡ Æ®·ÒºóÀ» °¡ÇÏ¸é ¼ö¿ë¼º ¼¶À¯¼Ò·Î ÀüȯµÇ´Â ¼ºÁúÀ» °¡Áö°í ÀÖ´Ù. Ç÷¾×ÀÀ°í¿¡ ÀÖ¾î¼ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù. Ç÷¾×ÀÀ°í ÀÎÀÚ¹øÈ£ IÀÌ´Ù. |
||
| FDP(s) | 1) Fibrinolytic split Products(= FSP) 2) Fibrinogen Degradation Products |
|---|---|
| FBG | fasting blood glucose; fibrinogen; foreign body granulomatosis |
| fbg | fibrinogen |
| FDP | fibrin degradation product; fibrinogen degradation product; flexor digitorum profundus; frontodextra... |
| FG | fasciculus gracilis; fast-glycolytic [fiber]; Feeley-Gorman [agar]; fibrinogen; Flemish giant [rabbi... |
| FDP | Fibrin-fibrinogen degradation product |
|---|---|
| FB | Fibrinogen |
| FBG | Fibrinogen |
| FG | Fibrinogen |
| FIB | Fibrinogen |
| fibrin fibrinogen degradation products | <chemical> Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. Fdp and their complexes profoundly impair the haemostatic process and are a major cause of haemorrhage in intravascular coagulation and fibrinolysis. Pharmacological action: antithrombins. (12 Dec 1998) |
|---|---|
| fibrinogen | <protein> Soluble plasma protein (340 kD, 46 nm long), composed of 6 peptide chains (2 each of A_, B_ and _) and present at about 2-3 mg/ml. (12 Nov 1997) |
| fibrinogen-fibrin conversion syndrome | <syndrome> A syndrome characterised by hypofibrinogenaemia with incoagulable blood; it may be seen in abruptio placentae, prolonged retention of a dead foetus in an Rh-isosensitised mother, haemolytic blood reactions, bilateral renal cortical necrosis, and cases of trauma. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
³ì½ÊÀÚÆÄÀ̺긮³ë°ÕÁÖ - »õâ
|
³ì½ÊÀÚ |
A35504321 | Human fibrinogen dried | Àü¹®ÀǾàǰ | ±Þ¿© |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|